Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000019

Options or other derivatives

  • SVP, Chief Financial Officer acquired 244,052 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Branning Todd P. · SVP, Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-01-22 Grant or award : show line 1 in the form Stock Option +163,666 163,666 D
2019-01-22 Grant or award : show line 2 in the form Restricted Stock Units +80,386 80,386 D
Loading xslF345X03/wf-form4_154836993308270.xml…